Rena M Conti

7PUBLICATIONS

13CO-AUTHORS

Industrial molecular engineering of nucleic acids and proteinsSerious gamesHaematological tumoursPharmacogenomicsPharmaceutical delivery technologies

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (7)

Sort by Publication Date:

|Jul 06, 2026

An evaluation of the US public-private Combating Antibiotic-Resistant Bacteria Accelerator (CARB-X) initiative.

|Feb 25, 2026

Adverse events administering glucagon-like peptide-1 receptor agonists: a cross-sectional study.

T Joseph Mattingly, Emeka Elvis Duru, Rena M Conti

|Jun 03, 2025

Observational survey of financial difficulties among patients with multiple myeloma and chronic lymphocytic leukaemia treated at US community oncology clinics (Alliance A231602CD).

Rena M Conti, Shaylene McCue, Travis Dockter

|Dec 04, 2024

Predicting the next round of drugs for Medicare price negotiation.

Matthew Vogel, Adam Tellier, Rena M Conti

|Jan 31, 2024

Medicare price negotiation and pharmaceutical innovation following the Inflation Reduction Act.

Matthew Vogel, Pragya Kakani, Amitabh Chandra

|Nov 07, 2023

The estimated annual financial impact of gene therapy in the United States.

Chi Heem Wong, Dexin Li, Nina Wang

Pageof 2

Frequent Collaborators

Matthew Vogel

Shaylene McCue

Travis Dockter

Heather Gunn

Stacie Dusetzina

Antonia Bennett

Selina Chow

Heather B Neuman

Elisa Weiss

T Joseph Mattingly

Frequent Collaborators

Matthew Vogel

Shaylene McCue

Travis Dockter

Heather Gunn